Mass. Hits Hedge Fund For Insider-Trading On Expert Network Info.

Mar 10 2011 | 12:07pm ET

Massachusetts regulators have accused a Boston-area hedge fund of insider-trading, the latest such case to involve hedge funds' use of expert networks.

Risk Reward Capital Management's James Silverman received nonpublic information about at least two pharmaceutical companies from Guidepoint Global consultants, the lawsuit, filed by Secretary of the Commonwealth William Galvin, alleges. Guidepoint has not been accused of any wrongdoing, and the alleged tipsters were not identified in the complaint.

Galvin said that Silverman used the insider information to revive the flagging fortunes of his $24 million RRC Bio Fund. The hedge fund, like most others, took a beating in 2008, but posted back-to-back years of 50%-plus returns in 2009 and last year.

"With access to Guidepoint, the fund began a dramatic resurgence," the lawsuit alleges. "These returns were generated, at least in part, upon Silverman's receipt of material non-public information he received through Guidepoint consultants."

Galvin's allegations mirror those made by the Justice Department in their ongoing insider-trading probe. Eight people with ties to another expert-network firm, Primary Global Research, have been charged in that case.

Silverman allegedly got insider information on drug trials conducted by Ariad Pharmaceuticals, based, like RRC, in Cambridge, Mass., and California-based Questor Pharmaceuticals.

"Silverman apparently also knew that he should not have received this information, as he deleted his notes containing the study results prior to producing them to the [Securities] Division in response to its subpoena," the lawsuit adds.

Guidepoint, for its part, said it has "cooperated fully" with the investigation.


In Depth

GSAM's Papagiannis: Liquid Alternatives For The Long Run

Apr 21 2017 | 8:44pm ET

Interest in liquid alternatives cooled a bit last year amid a broad shift in investor...

Lifestyle

Aston Martin Returns To Debt Market As DB11 Drives Turnaround

Mar 31 2017 | 5:21pm ET

James Bond’s preferred carmaker is returning to the public debt markets for the...

Guest Contributor

Debunking Conventional Investment Wisdom (Part II)

Apr 17 2017 | 5:56pm ET

The alternative investment industry is currently replete with buzzwords around data...